Novo Holdings Asia's Amit Kakar speaks at the Asia Summit on Global Health in Hong Kong (courtesy HKTDC)
Novo Holdings’ head of Asia on investing in ‘China for China,’ and staying out of biotech (for now)
Geopolitical headwinds may have given some foreign life sciences investors pause about investing in China. But for Novo Holdings Asia, it’s a good time to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
